RXST - RxSight, Inc.

14.95
0.225   1.505%

Share volume: 997,553
Last Updated: 04-25-2025
Medical Equipment/Ophthalmic Goods: 0.00%

PREVIOUS CLOSE
CHG
CHG%
$14.72
0.22
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
19%
Profitability 0%
Dept financing 5%
Liquidity 65%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
3.32%
1 Month
-43.71%
3 Months
-53.06%
6 Months
-70.25%
1 Year
-71.93%
2 Year
-16.48%
Key data
Stock price
$14.95
P/E Ratio 
0.00
DAY RANGE
$14.49 - $15.06
EPS 
-$0.55
52 WEEK RANGE
$13.50 - $66.54
52 WEEK CHANGE
-$71.93
MARKET CAP 
1.386 B
YIELD 
N/A
SHARES OUTSTANDING 
37.196 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
0.28
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$884,803
AVERAGE 30 VOLUME 
$1,340,386
Company detail
CEO: Ronald M. Kurtz
Region: US
Website: rxsight.com
Employees: 220
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Ophthalmic Goods
Sector: Manufacturing

RxSight, Inc. engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. The company was formerly known as Calhoun Vision, Inc.

Recent news
loading